Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-21

Study Completion Date

2021-06-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Eighty percent of nosocomial UTI caused by indwelling urinary catheters and so known-as catheter-associated UTI. CAUTI leads to multiple local and systemic derangements such as suprapubic pain, dysuria, cystitis, pyelonephritis, septicemia, and even septic shock.

This study will be conducted up on 100 patients (50 per each group) with long term catheterization to assess efficacy of noble metal alloy coated catheter in reducing CAUTI.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)

NCT01054690

Urinary Tract Infection

COMPLETED NA

Alcohol Locks for the Prevention of Tunneled Catheter-related Infections

NCT00122642

Bacteremia

COMPLETED PHASE2/PHASE3

Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters

NCT02915692

Surgery

TERMINATED

Comparison of Infection Rates Among Patients Using Two Catheter Access Devices

NCT00965198

Catheter-Related Infections Bacteremia

COMPLETED

Developing and Maintaining a Central Venous Catheter Registry

NCT01165411

Infection

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective controlled randomized study conducted upon 100 patients at Alexandria University hospital from 21 May 2020 to 21 December 2020. Patients enrolled will be divided into two equal groups according to the urethral catheter inserted

The institutional ethics committee for research approved the study. Written informed consent was obtained from all participants. In addition to taking the patients' medical history and completing general and physical examinations, physicians will choose proper catheter size all perform catheterization using aseptic technique according to guidelines of proper aseptic catheterization. Urologist ensures comparable catheter size and amount of balloon inflation.

An aseptic non-touch technique (ANTT) must be used to obtain catheter specimen urine following these steps:

* After catheterization apply clamp 10 cm distal to meatus then after few minutes clean the drainage port with alcohol and allow to dry then insert the syringe tip into the drainage port.
* Three to five ml of urine collected in sterile disposable plastic cup at day zero (within 2 hours of catheterization), day ten and day twenty post catheterization.
* The urine subjected to routine urine analysis, urine culture and sensitivity.

Appropriate statistical tests will be used to indicate the frequency and type of CAUTI as well as to assess catheter tolerance in each arm, followed by a comparison to conclude the results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Tract Infections Catheter Infection Catheter-Related Infections Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bactiguard urethral catheter

Group A: Fifty Patients with urethral catheter using noble metal alloy coated catheter (Bactiguard AB, Stockholm ,Sweden).

Group Type ACTIVE_COMPARATOR

Urethral catheter

Intervention Type DEVICE

All Patients will have urethral catheterization with either Noble Metal Alloy coated catheter or Silicon Foley catheter.

Silicone Foley urethral catheter

Group B: Fifty Patients with urethral catheter using silicone Foley catheter (Well Lead, Guangzhou, China).

Group Type ACTIVE_COMPARATOR

Urethral catheter

Intervention Type DEVICE

All Patients will have urethral catheterization with either Noble Metal Alloy coated catheter or Silicon Foley catheter.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Urethral catheter

All Patients will have urethral catheterization with either Noble Metal Alloy coated catheter or Silicon Foley catheter.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patient under age of 80 years old who need prolonged urethral catheterization (more than 2 weeks) as a method of bladder drainage.

Exclusion Criteria

* Patients with current or recent symptomatic urinary tract infection.
* Antibiotic use currently or within 7 days prior to inclusion.
* Known hypersensitivity to latex, silver salts or hydrogel.
* Patients with recent surgical intervention in the urinary tract.
* Patients with anatomic or functional upper urinary tract issues (e.g reflux, stones, etc.)
* Uncontrolled DM. Patients on corticosteroid treatment. Immunosuppressed patients. Patients received pelvic irradiation.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No